Dr. Collins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
Dallas, TX 75390Phone+1 214-645-8600Fax+1 214-645-2661
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1989
Baylor University Medical CenterResidency, Internal Medicine, 1984 - 1987
University of Missouri Kansas City School of MedicineClass of 1984
Certifications & Licensure
TX State Medical License 1986 - 2026
CA State Medical License 1987 - 2024
OK State Medical License 1985 - 1986
AL State Medical License 1965 - 1965- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
- Super Doctor SuperDoctors.com
Clinical Trials
- Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) Start of enrollment: 2003 Dec 01
- Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine Start of enrollment: 2013 Aug 01
- Allograft for Sickle Cell Disease and Thalassemia Start of enrollment: 2014 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Racial and ethnic disparities in Acute Myeloid Leukemia: 15-year experience at a safety net hospital system.Sharlene Dong, Naveen Premnath, Navid Sadeghi, Radhika Kainthla, Stephen S Chung
Leukemia Research. 2024-06-01 - 5 citationsCrenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML.Eunice S Wang, Aaron D Goldberg, Martin Tallman, Roland B Walter, Chatchada Karanes
Journal of Clinical Oncology. 2024-05-20 - Genomic heterogeneity within B/T mixed phenotype acute leukemia in a context of an immunophenotype.Ruifang Zheng, Franklin Fuda, Jeffrey R Gagan, Olga K Weinberg, Prasad Koduru
Leukemia Research Reports. 2024-01-01
Journal Articles
- LILRB4 Signalling in Leukaemia Cells Mediates T Cell Suppression and Tumour InfiltrationNam Nguyen, Robert Collins, Hong Zhu, Nisha Unni, Benjamin Chen, Jaehyup Kim, Nature
Abstracts/Posters
- Precision Medicine Treatment in Older AML: Results of Beat AML Master TrialClinically Relevant AbstractRobert H. Collins, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Younger Patients with Newly Diagnosed FLT3-Mutant AML Treated with Crenolanib Plus Chemotherapy Achieve Adequate Free Crenolanib Levels and Durable RemissionsRobert H. Collins, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Remembering Dr. Eugene P. Frenkel, Who Led Division of Hematology and Oncology for 30 Years at UT SouthwesternJune 23rd, 2019
Researchers Uncover Mutated Genes Involved in Lung Cancer; One Affects NonsmokersOctober 24th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
